PHS
HUM icon

PFM Health Sciences’s Humana HUM Stock Holding History

PFM Health Sciences’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-87,900
Closed -$42.7M – 87
2023
Q1 		$42.7M Buy
+87,900
New +$43.5M 1.88% 18
2015
Q3 		– Sell
-687,100
Closed -$3.81M – 91
2015
Q2 		$3.81M Buy
+687,100
New +$128M 0.1% 76

Other funds holding HUM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PFM Health Sciences's HUM Position: Q4 2025 in Review

PFM Health Sciences sold out of Humana (HUM) in Q4 2025, closing a stake of 3,648 shares — an estimated $949K sold.

PFM Health Sciences first reported a position in HUM in Q3 2013 and held it in 45 quarters. The position peaked at $149M in Q2 2019. 862 funds tracked by Wall St. Rank hold HUM as of Q4 2025.

  • PFM Health Sciences reported no remaining Humana position as of Q4 2025 after selling out during the quarter.
  • PFM Health Sciences sold 3,648 Humana shares in Q4 2025, an estimated $949K.
  • PFM Health Sciences first reported a position in Humana in Q3 2013 and held it in 45 quarters.
  • PFM Health Sciences's Humana position peaked at $149M in Q2 2019.
  • 862 funds tracked by Wall St. Rank held Humana as of Q4 2025.

Based on PFM Health Sciences's 13F filing for Q4 2025, filed 17 Feb 2026.